Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Total Non-Current Liabilities (2016 - 2025)

Wave Life Sciences (WVE) has disclosed Total Non-Current Liabilities for 11 consecutive years, with $17.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Non-Current Liabilities fell 27.92% year-over-year to $17.2 million, compared with a TTM value of $17.2 million through Dec 2025, down 27.92%, and an annual FY2025 reading of $17.2 million, down 27.92% over the prior year.
  • Total Non-Current Liabilities was $17.2 million for Q4 2025 at Wave Life Sciences, down from $23.1 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $161.5 million in Q1 2023 and bottomed at $17.2 million in Q4 2025.
  • Average Total Non-Current Liabilities over 5 years is $80.6 million, with a median of $101.7 million recorded in 2021.
  • The sharpest move saw Total Non-Current Liabilities soared 59.86% in 2023, then plummeted 77.63% in 2024.
  • Year by year, Total Non-Current Liabilities stood at $102.4 million in 2021, then increased by 9.42% to $112.1 million in 2022, then plummeted by 63.42% to $41.0 million in 2023, then crashed by 41.8% to $23.9 million in 2024, then fell by 27.92% to $17.2 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for WVE at $17.2 million in Q4 2025, $23.1 million in Q3 2025, and $17.8 million in Q2 2025.